USPTO serial 79320158
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Petach Tikva, IL
Petach Tikva, IL
Petach Tikva, IL
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bharati Bakshani
Bharati Bakshani Ladas & Parry, LLP1040 Avenue of the AmericasNew York, NY 10018UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug carriers for medical use, namely, polymer-lipid matrix formulation for localized drug delivery; drug delivery formulations for medical use, namely, drug delivery agents in the form of polymer-lipid matrix for sustained drug delivery; drug delivery formulations for medical use, namely, drug delivery formulations being drug delivery agents in the form of powders and pastes that provide sustained release of the active ingredients for a wide variety of pharmaceuticals; antibiotic delivery systems comprising polymer-lipid based matrix formulation for the continuous release of antibiotic drugs for medical use, namely for the prevention and treatment of infections associated with surgical procedures; drug delivery systems for medical use, namely, drug delivery agents being polymeric based particles coated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being polymeric based particles impregnated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being mineral based particles coated with polymer-lipid matrix for sustained antibiotic drug delivery; drug delivery systems for medical use, namely, drug delivery agents being mineral based particles impregnated with polymer-lipid matrix for sustained antibiotic drug delivery | ACTIVE | — |
| 010 | Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all impregnated with polymer-lipid matrix for sustained antibiotic drug delivery; Drug delivery systems for medical use, namely, surgical instruments and materials being sutures, orthopedic and dental nails, screws, staples, wires, pins, sponges, metal and polymeric implants, all coated with polymer-lipid matrix for sustained antibiotic drug delivery | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 9, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 9, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 30, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 30, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 30, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 14, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 14, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 6, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 6, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 6, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 6, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 6, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 6, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 8, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 25, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 24, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 20, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 16, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |